Prostate Cancer - Results from #920

Perception of cure in prostate cancer: human-led and artificial intelligence-assisted landscape review and linguistic analysis of literature, social media and policy documents. May 16, 2024

Deciphering the Transcription Factor Landscape in Neuroendocrine Prostate Cancer Progression: A Novel Approach to Understand NE Transdifferentiation. May 16, 2024

The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2b. May 16, 2024

Prostate cancer screening-current overview. May 16, 2024

Investigating MRI-Associated Biological Aspects of Racial Disparities in Prostate Cancer for African American and White Men. May 16, 2024

ProstaMine: a bioinformatics tool for identifying subtype-specific co-alterations associated with aggressiveness in prostate cancer. May 16, 2024

The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score. May 16, 2024

Pelvic exenteration for locally advanced and recurrent prostate cancer. May 16, 2024

Bellmunt risk score as a survival predictor in patients with metastatic castration-resistant prostate cancer. May 16, 2024

Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs. May 15, 2024

Genetic Testing in Men With Metastatic Castration-Resistant Prostate Cancer. May 15, 2024

Prevalence of DNA-Repair Gene Mutations in Mexican Men with Prostate Cancer. May 15, 2024

Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial. May 15, 2024

A bicentric retrospective study of the correlation of EAU BCR risk groups with 18F-PSMA-1007 PET/CT detection in prostate cancer biochemical recurrence. May 15, 2024

Targeted microwave ablation for prostate cancer (FOSTINE1b): a prospective 'ablate-and-resect' study. May 15, 2024

Biochemical Response of <0.1 ng/ml Predicts Therapy-free Survival of Prostate Cancer Patients following Prostate-specific Membrane Antigen-targeted Salvage Surgery. May 15, 2024

Determinants of receipt of prostate cancer screening among men living with HIV enrolled in an urban HIV Clinic in the United States over the period of 2000-2020. May 14, 2024

Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification. May 14, 2024

Robot-Assisted Radical Prostatectomy Performed with the Novel Hugo™ RAS System: A Systematic Review and Pooled Analysis of Surgical, Oncological, and Functional Outcomes. May 14, 2024

Contemporary Diagnosis of Very Low-risk Prostate Cancer in a Multihospital Health Care System. May 14, 2024

Page 47 of 1437